Enanta Pharmaceuticals (ENTA) Tax Rate Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -550.00 |
| Dec 31, 2025 | -203.00 |
| Sep 30, 2025 | -208.00 |
| Jun 30, 2025 | -187.00 |
| Mar 31, 2025 | 430.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | -287.00 |
| Jun 30, 2024 | 1,383.00 |
| Mar 31, 2024 | 127.00 |
| Dec 31, 2023 | 171.00 |
| Sep 30, 2023 | 483.00 |
| Jun 30, 2023 | -1,350.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 14,521.00 |
| Jun 30, 2022 | -2,670.00 |
| Dec 31, 2021 | -2,822.00 |
| Sep 30, 2021 | -8,780.00 |
| Jun 30, 2021 | -527.00 |
| Mar 31, 2021 | -6,388.00 |
| Dec 31, 2020 | 1,828.00 |
| Sep 30, 2020 | -5,188.00 |
| Jun 30, 2020 | 4,740.00 |
| Mar 31, 2020 | 37,999.00 |
| Dec 31, 2019 | -248.00 |
| Sep 30, 2019 | -2,916.00 |
| Jun 30, 2019 | -2,942.00 |
| Mar 31, 2019 | -37,045.00 |
| Dec 31, 2018 | -1,122.00 |
| Sep 30, 2018 | 5,715.00 |
| Jun 30, 2018 | 4,814.00 |
| Mar 31, 2018 | 6,976.00 |
| Dec 31, 2017 | 4,740.00 |
| Sep 30, 2017 | -214.00 |
| Jun 30, 2017 | -10,035.00 |
| Mar 31, 2017 | -170,862.00 |
| Dec 31, 2016 | 345.00 |
| Sep 30, 2016 | -7,037.00 |
| Jun 30, 2016 | 4,609.00 |
| Mar 31, 2016 | 170,986.00 |
| Dec 31, 2015 | 1,333.00 |
| Sep 30, 2015 | 3,989.00 |
| Jun 30, 2015 | -2,178.00 |